Anti-CT83 Antibody

cancer/testis antigen 83
Recommended Applications
Product Description
Polyclonal Antibody against Human CT83
Alternative Gene Names
CXorf61, FLJ20611, FLJ22913, KK-LC-1
Product Number
Unit Size
Lot dependent
>10 in Stock
Ready to Ship
Target Protein
cancer/testis antigen 83
Target Gene
Antigen Sequence
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
Verified Species Reactivity
Interspecies Information

Highest antigen sequence identity to the following orthologs:

Mouse ENSMUSG00000051243 (30%)

Rat ENSRNOG00000050714 (30%)

40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Purification Method
Affinity purified using the PrEST antigen as affinity ligand
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Unit Size
100 µl
Current Lot
Produced on demand. Contact for more information.
Product Data Sheet
Immunohistochemistry (IHC)

Recommended conditions:

Dilution: 1:200 - 1:500

Retrieval method: HIER pH6

Western Blot (WB)

Recommended conditions:

Working concentration: 0.04-0.4 µg/ml

Western Blot (WB)

Validated in Western blot using relevant lysates (see Western blot application images above)

Protein Name
cancer/testis antigen 83
Gene Name
Alternative Gene Names
CXorf61, FLJ20611, FLJ22913, KK-LC-1
UniProt ID
Gene (Ensembl)
Entrez Gene ID
Normally shipped at ambient temperature
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Human Protein Atlas

This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.

All characterization data for ENSG00000204019 on the Human Protein Atlas

Paret C, Simon P, Vormbrock K, Bender C, Kölsch A, Breitkreuz A, Yildiz Ö, Omokoko T, Hubich-Rau S, Hartmann C, Häcker S, Wagner M, Roldan DB, Selmi A, Türeci Ö, Sahin U

CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer

Oncotarget , 2015 Sep 22; 6(28):25356-25367. Epub 2015 Jul 29

PubMed ID: 26327325 DOI: 10.18632/oncotarget.4516

Did we miss your publication?

Have you published using HPA004773? Please let us know and we will be happy to include your reference on this page.

Read more

Join the Explorer Program

Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers 50% of the product price as a refund, or 50% discount on your next vial purchase.

Read more

Alternative Antibodies
Corresponding Antigens


Our customer support and expert scientific support teams are here to help you succeed in your research.

Get in touch